In vivo antitumoral effect of 4-nerolidylcatechol (4-NC) in NRAS-mutant human melanoma
- 22 April 2020
- journal article
- research article
- Published by Elsevier BV in Food and Chemical Toxicology
- Vol. 141, 111371
- https://doi.org/10.1016/j.fct.2020.111371
Abstract
No abstract availableKeywords
Funding Information
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (303925/2014-0, 304339/2017-2, 385282/2011-7, 442212/2014-3)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2014/06959-0, 2014/24400-0, 2017/04926-6, 2017/07010-2)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (88881.068413/2014-01)
This publication has 23 references indexed in Scilit:
- Estimation of rat mammary tumor volume using caliper and ultrasonography measurementsLab Animal, 2013
- Penetration of anticancer drugs through tumour tissue as a function of cellular packing density and interstitial fluid pressure and its modification by bortezomibBMC Cancer, 2012
- Proteasome inhibition and ROS generation by 4-nerolidylcatechol induces melanoma cell deathPigment Cell & Melanoma Research, 2012
- NRAS mutation status is an independent prognostic factor in metastatic melanomaCancer, 2011
- Regulation of Granulocyte and Macrophage Populations of Murine Bone Marrow Cells by G-CSF and CD137 ProteinPLOS ONE, 2010
- Apoptosis induction by 4-nerolidylcatechol in melanoma cell linesToxicology in Vitro, 2009
- The origins of the identification and isolation of hematopoietic stem cells, and their capability to induce donor-specific transplantation tolerance and treat autoimmune diseasesBlood, 2008
- In Vitro and In Vivo Inhibition of Skin Matrix Metalloproteinases by Pothomorphe umbellata Root ExtractPhotochemistry and Photobiology, 2006
- Anti-inflammatory and analgesic properties of water–ethanolic extract from Pothomorphe umbellata (Piperaceae) aerial partsJournal of Ethnopharmacology, 2005
- 4-Nerolidylcatechol from Potomorphe umbellata*Planta Medica, 1980